Linked Life Data

7580067

Source:http://linkedlifedata.com/resource/pubmed/id/7580067

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1995-12-13
pubmed:abstractText
Anti-Cerebral Thromboembolism Injection (ACTI), applied intravenously in Cattaneo's animal model of arterial thrombosis, could significantly reduce the weight of thrombus, blood viscosities, plasma TXB2 level and delay the prothrombin time, compared to control group (P < 0.05). From this trial, it was indicated that ACTI's reducing thrombosis action was the result of inhibiting aggregation and releasing of platelets through reducing whole blood viscosities and TXB2 level.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1003-5370
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
424-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[Study of anti-cerebral thromboembolism injection's activity on experimental arterial thrombosis and its therapeutical mechanism].
pubmed:affiliation
Dongzhimen Hospital, Beijing University of TCM.
pubmed:publicationType
Journal Article, English Abstract